Related Experiment Video
Updated: Aug 12, 2026

Yeast Luminometric and Xenopus Oocyte Electrophysiological Examinations of the Molecular Mechanosensitivity of TRPV4
Published on: December 31, 2013
Differential type 4 cAMP-specific phosphodiesterase (PDE4) expression and functional sensitivity to PDE4 inhibitors
Abstract:
It has been suggested that the rat is relatively more susceptible to toxicity induced by inhibitors for type 4 cAMP-specific phosphodiesterase (PDE4). In this study designed to elucidate possible biochemical basis for the higher susceptibility, we compared PDE4 expression levels and their functional relevance among rats, monkeys and humans. In several toxicologically relevant tissues and blood leukocytes, the mRNA expression levels of PDEs 4A, 4B, 4C and 4D were significantly higher in rats than in humans. We confirmed that higher PDE4 expression levels were correlated with a higher enzyme activity level in rat leukocytes. The PDE4 enzyme activity level of leukocytes in monkeys fell between that of rats and humans. Functionally, the potencies of the PDE4 inhibitors rolipram, SB 207499 and SCH 351591 in inhibiting tumor necrosis factor production from leukocytes were in the following order: rat > monkey > human. In addition, rolipram was about 10-fold more potent in rats than in humans in inhibiting phenylephrine-induced contraction of renal artery. These inhibitors were confirmed to be highly selective for PDE4 in comparison to all other PDE families, and to inhibit rat and human PDE4s with identical potencies. Taken together, these results suggest that the higher susceptibility of rats to PDE4 inhibitor-induced toxicity might be due to their higher expression levels of PDE4, and that PDE4 inhibitors may be safer in humans than in monkeys and, particularly, rats.
Insights
Rats exhibit higher susceptibility to phosphodiesterase 4 (PDE4) inhibitor toxicity due to elevated PDE4 expression. This suggests PDE4 inhibitors may be safer for humans compared to rats and monkeys.
Area of Science:
- Pharmacology
- Toxicology
- Biochemistry
Background:
- Rats show increased susceptibility to phosphodiesterase 4 (PDE4) inhibitor toxicity.
- The biochemical basis for this higher susceptibility requires elucidation.
Purpose of the Study:
- To compare PDE4 expression and functional relevance in rats, monkeys, and humans.
- To investigate the biochemical mechanisms underlying PDE4 inhibitor toxicity.
Main Methods:
- Quantified mRNA expression levels of PDE4 subtypes (4A, 4B, 4C, 4D) in relevant tissues and leukocytes.
- Assessed PDE4 enzyme activity in leukocytes.
- Evaluated the potency of PDE4 inhibitors (rolipram, SB 207499, SCH 351591) in inhibiting TNF production and phenylephrine-induced contraction.
Main Results:
- Rats displayed significantly higher PDE4 mRNA expression than humans.
- Higher PDE4 expression correlated with increased enzyme activity in rat leukocytes.
- PDE4 inhibitor potency followed the order: rat > monkey > human for inhibiting TNF production and vascular contraction.
Conclusions:
- Elevated PDE4 expression levels in rats likely contribute to their heightened susceptibility to PDE4 inhibitor toxicity.
- PDE4 inhibitors may pose a lower safety risk in humans compared to monkeys and rats.
More Related Videos
08:22Measurement of 3-Dimensional cAMP Distributions in Living Cells using 4-Dimensional (x, y, z, and λ) Hyperspectral FRET Imaging and Analysis
Published on: October 27, 2020
06:03Real-Time cAMP Dynamics in Live Cells Using the Fluorescent cAMP Difference Detector In Situ
Published on: March 22, 2024
Related Concept Videos
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
GPCRs Regulate Adenylyl Cylase Activity
Two...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Pharmacodynamic Responses: Different Types
Dipeptidyl Peptidase 4 Inhibitors